EP3332767
Vökvaefnablanda til innöndunar sem inniheldur RPL554
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
15.9.2015EP published:
20.3.2019EP application number:
17207623.4
EP translation filed:
12.6.2019Grant published:
15.8.2019EPO information:
European Patent Register
Max expiry date:
14.9.2035Expiry date:
14.9.2026Next due date:
30.9.2026
Title:
LIQUID INHALATION FORMULATION COMPRISING RPL554
Timeline
Today
15.9.2015EP application
20.3.2019EP Publication
12.6.2019Translation submitted
15.8.2019Registration published
14.9.2026Expires
Owner
Name:
Verona Pharma PLCAddress:
One Central Square, Cardiff CF10 1FS, GB
Inventor
Name:
SPARGO, Peter LionelAddress:
Canterbury, Kent CT2 8NR, GB
Name:
FRENCH, Edward JamesAddress:
Canterbury, Kent CT1 3LX, GB
Name:
HAYWOOD, Philip AAddress:
Buntingford, Hertfordshire SG9 0DH, GB
Agent
Name:
Tego ehf.Address:
Pósthólf 8129, 128, Reykjavík,
Priority
Number:
201416274Date:
15.9.2014Country:
GB
Number:
201504662Date:
19.3.2015Country:
GB
Classification
Categories:
A61K 9/12, A61K 31/495, A61P 11/08
Annual fees
Number
Paid
Expires
Payer
Number: 5
Paid: 7.8.2019
Expires: 14.9.2020
Payer: Árnason Faktor
Number: 6
Paid: 6.8.2020
Expires: 14.9.2021
Payer: Árnason Faktor ehf.
Number: 7
Paid: 10.8.2021
Expires: 14.9.2022
Payer: Árnason Faktor ehf.
Number: 8
Paid: 16.8.2022
Expires: 14.9.2023
Payer: Árnason Faktor ehf.
Number: 9
Paid: 5.9.2023
Expires: 14.9.2024
Payer: Árnason Faktor ehf.
Number: 10
Paid: 7.8.2024
Expires: 14.9.2025
Payer: Árnason Faktor ehf.
Number: 11
Paid: 10.9.2025
Expires: 14.9.2026
Payer: Árnason Faktor ehf.